Authors Yeung J, Holinstat M
Received 20 July 2012
Accepted for publication 20 July 2012
Published 3 August 2012 Volume 2012:3 Pages 49—50
Yeung J, Holinstat M. Newer agents in antiplatelet therapy: a review. Journal of Blood Medicine. 2012;3:33–42.
An error was made on page 37, section GPVI receptor antagonists, in the above paper. The company currently moving Revacept® through clinical development is in fact advanceCor GmbH (Martinsried, Germany) and not ABX-CRO/Medifacts GmbH (Goerlitz, Saxony, Germany).
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]